Previous 10 | Next 10 |
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is one of today's top gainers. The company's shares have moved 37.98% on the day to $5.39. Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The c...
2024-04-03 10:00:34 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Eli ...
2024-04-03 08:46:18 ET DENVER, Colo., Apr 03, 2024 ( 247marketnews.com )- Vanda Pharmaceuticals Inc. (NASDAQ: VNDA ) today announced that the U.S. Food and Drug Administration approved Fanapt ® (iloperidone), an atypical antipsychotic agent that has been used for the acute ...
2024-04-03 06:22:57 ET Vanda Pharmaceuticals ( NASDAQ: VNDA ) shares jumped 29% premarket on Wednesday after the U.S. Food and Drug Administration (FDA) cleared its Fanapt (iloperidone) tablets for the acute treatment of manic or mixed episodes associated with bipolar I disorder...
2024-04-03 05:15:26 ET More on related stocks: Dave & Buster's Q4 Earnings: Ready To Move Higher, 4x EBITDA Dave & Buster's Entertainment, Inc. (PLAY) Q4 2023 Earnings Call Transcript Intel Corporation (INTC) New Segment Reporting Webinar (Transcript) ...
Vanda Pharmaceuticals' Fanapt® (iloperidone) Receives U.S. FDA Approval for the Acute Treatment of Bipolar I Disorder PR Newswire Fanapt ® Treatment is Now Available to Adult Patients for the Acute Treatment of Manic or Mixed Episodes Associated with Bipolar ...
2024-04-02 16:43:27 ET Gainers: Sight Sciences ( SGHT ) +19% . Zapata Computing Holdings ( ZPTA ) +9% . Cal-Maine Foods ( CALM ) +6% . Vanda Pharmaceuticals ( VNDA ) +5% . iHeartMedia ( IHRT ) +5% . Losers: Ac...
2024-03-06 08:24:28 ET More on Pre-market losers & stocks. Datasea jumps 23% as subsidiary enters a potential $30M sale agreement Seeking Alpha’s Quant Rating on BeyondSpring Historical earnings data for BeyondSpring Financial information for Beyon...
2024-03-06 07:23:30 ET More on Vanda Pharmaceuticals Vanda Pharmaceuticals' Portfolio Likely Has Upside From 2024 Approvals, Underpinned By Cash Vanda Pharmaceuticals Inc. (VNDA) Q4 2023 Earnings Call Transcript Vanda Pharmaceuticals: FDA Approvals On Deck In 2024 Ma...
2024-02-23 17:39:49 ET Gainers: Sizzle Acquisition ( SZZL ) +12% . ImmunityBio ( IBRX ) +6% . E.W. Scripps ( SSP ) +5% . Outset Medical ( OM ) +5% . BigCommerce Holdings. ( BIGC ) +5% . Losers: EverQuote...
News, Short Squeeze, Breakout and More Instantly...
Vanda Pharmaceuticals Inc. Company Name:
VNDA Stock Symbol:
NASDAQ Market:
Vanda Pharmaceuticals Inc. Website:
2024-07-17 04:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-11 07:00:07 ET Charles Duncan from Cantor Fitzgerald issued a price target of $11.00 for VNDA on 2024-07-11 06:12:00. The adjusted price target was set to $11.00. At the time of the announcement, VNDA was trading at $5.21. VNDA currently trades -22.96% versus its...
Federal Court Allows Vanda's HETLIOZ® Patent Lawsuit to Proceed against Teva and Apotex PR Newswire WASHINGTON , July 1, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. District Court for the District of ...